Previous close | 0.5179 |
Open | 0.5150 |
Bid | 0.0000 x 1100 |
Ask | 0.0000 x 1800 |
Day's range | 0.5150 - 0.5650 |
52-week range | 0.5010 - 2.7350 |
Volume | |
Avg. volume | 2,085,830 |
Market cap | 158.308M |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.3800 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.08 |
Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website
Key Insights Significantly high institutional ownership implies American Well's stock price is sensitive to their...
Amwell’s Class A Common Stock continues to trade on the NYSEBoston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York Stock Exchange (NYSE) informing the company that it is not in compliance with the NYSE’s continued listing minimum price criteria with respect to its Class A common stock because the average closing price of the company’s Class A common stock